Revised Policy Set to Improve Kidney Transplant Waitlist Time for Black Candidates
The OPTN policy revision may increase some Black kidney candidates’ total waiting time, which is a major factor in their transplant priority for organ offers.
Diagnosis & Disease Information
Transplant Outcomes Mixed After New Kidney Allocation System Implemented
Kidney transplantation access increased for some groups, but so did the kidney discard rate.
Hepatitis C Guideline Updated for Chronic Kidney Disease Population
The update reflects advances in hepatitis C management, such as antiviral therapy, increased use of hepatitis C kidney grafts, and treatment of glomerular diseases associated with the virus.
COVID-19 Vaccines Reduce Risk of Severe Outcomes in CKD
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
Pediatric Kidney Transplant Rate Lower at For-Profit Dialysis Facilities
Dialysis facility profit status was associated with longer time to waitlisting and kidney transplantation, investigators reported.
Paxlovid Use for COVID-19 May Be Feasible in Advanced CKD
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
CellCept Approval Expanded to Include Pediatric Recipients of Heart, Liver Transplants
The expanded approval was based on pediatric extrapolation of efficacy from adequate and well-controlled studies and pharmacokinetic data in adult heart transplant and liver transplant patients.
Livtencity Approved for Post-Transplant Cytomegalovirus Infection
Livtencity is an orally bioavailable anti-CMV compound that targets and inhibits the UL97 protein kinase and its natural substrates.
Air Pollution May Up Risk for Adverse Transplant Outcomes
Moving to areas with low air pollution might improve outcomes for kidney transplant recipients, investigators suggested.
SARS-CoV-2 Infection Linked to Greater Decline in Kidney Allograft Function
Patients with moderate and severe infection experienced a 17.50% and 23.16% decrease in estimated glomerular filtration rate (eGFR), respectively, from baseline (before testing positive for SARS-CoV-2) to 90 days after the positive test.
- Loading...
Loading...
Next post in News
Loading... 
Loading...